A novel antigen biomarker for detection of high-level of Loa loa microfilaremia
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012461 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Sarah E Greene und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, United States of America. Hauptthemen laut MEDLINE: Loa, Loiasis, Antigens, Helminth, Enzyme-Linked Immunosorbent Assay. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, Foundation for Barnes- Jewish Hospital, Foundation for Barnes-Jewish Hospital.
Abstract (Originalsprache)
Background
Loiasis is a disease caused by the nematode Loa loa . Serious adverse events sometimes occur in people with heavy L . loa microfilaremia after ivermectin treatment. In regions of Central Africa where loiasis is endemic, this significantly impedes global elimination programs for lymphatic filariasis and onchocerciasis that use mass distribution of ivermectin. Improved diagnostic tests to identify individuals at increased risk of serious adverse events could facilitate efforts to eliminate lymphatic filariasis and onchocerciasis in this region. Methods and findings We previously identified the L . loa protein Ll-Bhp-1 in loiasis patient sera. Here, we further characterize Ll-Bhp-1 and report development of an antigen capture ELISA to detect this antigen. This assay detected Ll-Bhp-1 in 74 of 116 (63.8%) loiasis patient sera. Ll-Bhp-1 levels were significantly correlated with L . loa microfilarial counts, and the sensitivity of the assay was highest for samples from people with high counts, (94% and 100% in people with ≥20,000 and ≥50,000 microfilaria per milliliter of blood, respectively). The antigen was not detected in 112 sera from people with other filarial infections, or in 34 control sera from the USA.
Conclusions
This Ll-Bhp-1 antigen assay is specific for loiasis, and highly sensitive for identifying people with high L . loa microfilarial counts who are at increased risk for serious adverse events after ivermectin treatment. L . loa antigen detection has the potential to facilitate loiasis mapping efforts and programs to eliminate lymphatic filariasis and onchocerciasis in Central Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Division, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, United States of America.
- Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
- Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America.
- McDonnell Genome Institute, Washington University School of Medicine, St Louis, Missouri, United States of America.
- Parasites and Vector Biology research unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
- Research Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
ORCID-Profile: Sarah E Greene
Förderung
- Bill and Melinda Gates Foundation
- Foundation for Barnes- Jewish Hospital
- Foundation for Barnes-Jewish Hospital
Zitieren
APA
Greene, S. E., Huang, Y., Fischer, K., Rosa, B. A., Martin, J., Mitreva, M., Yates, D., Wanji, S., Kamgno, J., Budge, P. J., Weil, G. J., & Fischer, P. U. (2024). A novel antigen biomarker for detection of high-level of Loa loa microfilaremia. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012461
Vancouver
Greene SE, Huang Y, Fischer K, Rosa BA, Martin J, Mitreva M, et al. A novel antigen biomarker for detection of high-level of Loa loa microfilaremia. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012461
BibTeX
@article{Greene2024,
author = {Greene, Sarah E and Huang, Yuefang and Fischer, Kerstin and Rosa, Bruce A and Martin, John and Mitreva, Makedonka and Yates, Devyn and Wanji, Samuel and Kamgno, Joseph and Budge, Philip J and Weil, Gary J and Fischer, Peter U},
title = {A novel antigen biomarker for detection of high-level of Loa loa microfilaremia},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012461}
}
EUVIMED